Clinical trial
A Study of the Efficacy and Safety of 8 Mg Hydromorphone Hydrochloride Extended-Release Compared to Placebo in Subjects With Persistent Pain
NCT00365898 is registered in ClinicalTrials.gov with Purdue Pharma LP as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study of the Efficacy and Safety of 8 Mg Hydromorphone Hydrochloride Extended-Release Compared to Placebo in Subjects With Persistent Pain
- Lead sponsor
- Purdue Pharma LP
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- July 31, 2005
- Completion date
- July 31, 2005
- Enrollment
- 380
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.
chronic non-malignant pain